Clinical Trial Update: Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating donor stem cell transplant after chemotherapy for recurrent or refractory high-risk solid tumors in pediatric and adolescent/young ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Desmoplastic Small Round Cell Tumor
• Ewing Sarcoma
• Malignant Peripheral Nerve Sheath Tumor
• Neuroblastoma
• Rhabdomyosarcoma

Drugs mentioned

• Donor stem cell transplant

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Desmoplastic Small Round Cell Tumor, Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | Phase 2 | Status: TERMINATED | Results posted: 2025-06-29